Aspire Biopharma Holdings, Inc.
ASBP
$0.3366
-$0.0277-7.60%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.98M | -15.94M | -738.50K | -243.60K | -96.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.18M | 14.52M | -- | -- | -- |
| Change in Net Operating Assets | -340.40K | -326.30K | 1.22M | -290.20K | 40.70K |
| Cash from Operations | -1.14M | -1.75M | 479.60K | -533.80K | -56.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 38.30K | -- |
| Cash from Investing | -- | -- | -- | 38.30K | -- |
| Total Debt Issued | 0.00 | 3.05M | -492.50K | 492.50K | -- |
| Total Debt Repaid | 0.00 | -221.40K | -- | -- | -- |
| Issuance of Common Stock | 265.80K | -- | -- | 0.00 | 28.60K |
| Repurchase of Common Stock | -- | -- | -257.60K | -- | -- |
| Issuance of Preferred Stock | -- | -- | 257.60K | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -265.80K | 265.80K | -- | -- | -- |
| Cash from Financing | 0.00 | 3.09M | -492.50K | 492.50K | 28.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.14M | 1.34M | -12.90K | -3.10K | -27.70K |